Vicapsys Life Sciences, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Vicapsys Life Sciences, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2019 to Q4 2023.
  • Vicapsys Life Sciences, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $2.99M, a 8.9% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $2.99M +$244K +8.9% Dec 31, 2023 10-K 2024-10-21
Q4 2022 $2.74M +$185K +7.22% Dec 31, 2022 10-K 2024-10-21
Q4 2021 $2.56M +$48.8K +1.95% Dec 31, 2021 10-K 2023-04-14
Q4 2020 $2.51M +$158K +6.71% Dec 31, 2020 10-K 2022-03-16
Q4 2019 $2.35M Dec 31, 2019 10-K 2021-09-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.